Literature DB >> 16289657

The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.

Nithianandan Selliah1, Mingce Zhang, Dennis DeSimone, Hellen Kim, Michael Brunner, Richard F Ittenbach, Hallgeir Rui, Randy Q Cron, Terri H Finkel.   

Abstract

Although HIV-1 (HIV) replicates poorly in non-dividing CD4 lymphocytes, resting T cells contribute to the latent reservoir. The gammac-related cytokines reverse this block to HIV infection; however, the molecular mechanisms controlling this process are not understood. We asked whether the gammac-cytokine regulated transcription factor, signal transducer and activator of transcription 5 (STAT5), activates HIV transcription. We identified three regions in the long terminal repeat (LTR) as close matches to the STAT5 consensus-binding site and show that STAT5 binds the LTR during HIV infection. Expression of Janus kinase 3 (JAK3) or STAT5 in primary human CD4 T cells activated LTR transcription, while transactivation-incompetent dominant-negative STAT5 inhibited JAK3-induced LTR activity and infection of activated HIV-producing CD4 T-cells. In addition, overexpression of STAT5 increased virus production in unstimulated primary T cells - both the number of p24+ cells and their level of p24 production - suggesting that STAT5 promotes a permissive state for HIV infection. These data may have implications for regulation of latency and therapeutic strategies for control of HIV disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289657     DOI: 10.1016/j.virol.2005.09.063

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

Review 1.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

2.  HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

Authors:  K Sofia Appelberg; Mark A Wallet; Jared P Taylor; Melanie N Cash; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-12       Impact factor: 2.205

3.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 4.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 5.  New players in cytokine control of HIV infection.

Authors:  Massimo Alfano; Andrea Crotti; Elisa Vicenzi; Guido Poli
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 6.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

7.  Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.

Authors:  Jenny Louise Anderson; Rémi Fromentin; Giulio Maria Corbelli; Lars Østergaard; Anna Laura Ross
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

8.  Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

Authors:  Christina Gavegnano; Mervi Detorio; Catherine Montero; Alberto Bosque; Vicente Planelles; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

Review 9.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

10.  FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.

Authors:  Nithianandan Selliah; Mingce Zhang; Sara White; Philip Zoltick; Bassel E Sawaya; Terri H Finkel; Randy Q Cron
Journal:  Virology       Date:  2008-10-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.